Overlapping peptides of melanocyte differentiation antigen Melan- A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1

International Journal of Cancer

Volumn 75, Issue 3, 1998, Pages 451-458

  Schneider, Jörg ^a,c   Brichard, Vincent ^b   Boon, Thierry ^b   Meyer Zum Büschenfelde, Karl Hermann ^a   Wölfel, Thomas ^a,d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; TUMOR ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MELANOMA; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; COS CELLS; DNA, NEOPLASM; EPITOPES, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HLA-B ANTIGENS; HUMANS; MELANOMA; NEOPLASM PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032579240     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980130)75:3<451::AID-IJC20>3.0.CO;2-A     Document Type: Article

References (39)

1. BARNSTABLE, C.J., BODMER, W. F., BROWN, G., GALFRE, G., MILSTEIN, C., WILLIAMS, A.F. and ZIEGLER, A., Production of monoclonal antibodies to group A erythrocytes. HLA and other human cell surface antigens - new tools for genetic analysis. Cell. 14, 9-20 (1978).
2. BODMER, H., OGG, G., GOTCH, F. and MCMICHAEL, A., Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature (Lond.), 342, 443-446 (1989).
3. BOGEDAIN, C., WOLF, H., MODROW, S., STUBER, G. and JILG, W., Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J. Virol., 69, 4872-4879 (1995).
4. BOON, T., COULIE, P.G. and VAN DEN EYNDE, B., Tumor antigens recognized by T cells. Immunol. Today, 18, 267-268 (1997).
5. BRICHARD, V., VAN PEL, A., WÖLFEL, T., WÖLFEL, C., DE PLAEN, E., LETHÉ, B., COULIE, P.G. and BOON, T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 178, 489-495 (1993).
6. + cytotoxic T lymphocytes. J. exp. Med., 181, 363-368 (1995).
7. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
8. COLLINS, E.J., GARBOCZI, D.N. and WILEY, D.C., Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature (Lond.), 371, 626-629 (1994).
9. COULIE, P.G., BRICHARD, V., VAN PEL, A., WÖLFEL, T. SCHNEIDER, J., TRAVERSARI, C., MATTEI, S., DE PLAEN, E., LURQUIN, C., SZIKORA, J.-P., RENAULD, J.-C. and BOON, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 35-42 (1994).
10. CROWLEY, N.J., DARROW, T.L., QUINN-ALLEN, M.A. and SEIGLER, H.F., MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J. Immunol., 146, 1692-1699 (1991).
11. ENNIS, P.D., ZEMMOUR, J., SALTER, R.D. and PARHAM, P., Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc. nat. Acad. Sci. (Wash.), 87, 2833-2837 (1990).
12. ESPEVIK, T. and NISSEN-MEYER, J., A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods, 95, 99-105 (1986).
13. IKEDA, H., LETHÉ, B., LEHMANN, F., VAN BAREN, N., BAURAIN, J.-F., DE SMET, C., CHAMBOST, H., VITALE, M., MORETTA, A., BOON, T. and COULIE, P.G., Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity, 6, 199-208 (1997).
14. IMANISHI, T., AKAZA, T., KIMURA, A., TOKUNAGA, K. and GOJOBORI, T., Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: K. Tsuji, M. Aizawa and T. Sasazuki (eds.), 11th International Histocompatibility Workshop and Conference, Vol. 1, p. 1069, Oxford University Press, Yokohama (1991).
15. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.F., RIVOLTINI, L., TOPALIAN, S.L., MIKI, T. and ROSENBERG, S.A., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. nat. Acad. Sci. (Wash.), 91, 3515-3519 (1994a).
16. KAWAKAMI, Y., ELIYAHU, S., JENNINGS, C., SAKAGUCHI, K., KANG, X., SOUTHWOOD, S., ROBBINS, P.F., SETTE, A., APPELLA, E. and ROSENBERG, S.A., Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol., 154, 3961-3968 (1995).
17. KAWAKAMI, Y., ELIYAHU, S., SAKAGUCHI, K., ROBBINS, P.F., RIVOLTINI, L., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. exp. Med., 180, 347-352 (1994b).
18. LIVINGSTON, P.O., SHIKU, H., BEAN, M.A., OETTGEN, H.F. and OLD, L.J., Cell-mediated cytotoxicity for cultured autologous melanoma cells. Int. J. Cancer, 24, 34-44 (1979).
19. LOFTUS, D.J., CASTELLI, C., CLAY, T.M., SQUARCINA, P., MARINCOLA, F.M., NISHIMURA, M.I., PARMIANI, G., APPELLA, E. and RIVOLTINI, L., Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35). J. exp. Med., 184, 647-657 (1996).
20. MARCHAND, M. and 20 OTHERS, Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63, 883-885 (1995).
21. MCMICHAEL, A.J., PARHAM, P., RUST, N. and BRODSKY, F.M., A monoclonal antibody that recognizes an antigenic determinant shared by HLA-A2 and B17. Hum. Immunol., 1, 121-129 (1980).
22. MÜLLER, C., HERBST, H., ZIEGLER, A., UCHANSKA-ZIEGLER, B., SCHUNTER, F., STEIERT, I., MULLER, C. and WERNET, P., Characterization of a monoclonal anti-Bw4 antibody (Tü109): evidence for similar epitopes of the Bw4 and Bw6 antigens. Hum. Immunol., 14, 333-349 (1985).
23. RADKA, S.F., KOSTYU, D.D. and AMOS, D.B., A monoclonal antibody directed against the HLA-Bw6 epitope. J. Immunol., 128, 2804-2806 (1982).
24. RIVOLTINI, L., KAWAKAMI, Y., SAKAGUCHI, K., SOUTHWOOD, S., SETTE, A., ROBBINS, P.F., MARINCOLA, F.M., SALGALLER, M.L., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154, 2257-2265 (1995).
25. ROMERO, P. and 12 OTHERS, Cytolytic T lymphocyte recognition of the immunodominant HLA-A2.1-restricted Melan-A/MART-1 antigenic peptide in melanoma. J. Immunol., 159, 2366-2374 (1997).
26. SALTER, R.D., HOWELL, D.N. and CRESSWELL, P., Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics, 21, 235-246 (1985).
27. SCHNEIDER, J., Analyse der Erkennung des Melanomantigens Melan-A/MART-1 durch autologe zytotoxische T-Lymphozyten. Doctoral thesis at the Fachbereich Biologie. Johannes Gutenberg-Universität, Mainz (1996).
28. SCHOEL, B., ZUGEL, U., RUPPERT, J. and KAUFMANN, S.H., Elongated peptides, not the predicted nonapeptide, stimulate a major histocompatibility complex class I-restricted cytotoxic T lymphocyte clone with specificity for a bacterial heat shock protein. Europ. J. Immunol., 24, 3161-3169 (1994).
29. SIDNEY, J., DEL GUERCIO, M.F., SOUTHWOOD, S., ENGELHARD, V.H., APPELLA, E., RAMMENSEE, H.G., FALK, K., ROTZSCHKE, O., TAKIGUCHI, M., KUBO, R.T., GREY, H.M. and SETTE, A., Several HLA alleles share overlapping peptide specificities. J. Immunol., 154, 247-259 (1995).
30. STORKUS, W.J., ZEH III, H.J., MAEURER, M.J., SALTER, R.D. and LOTZE, M.T., Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J Immunol., 151, 3719-3727 (1993).
31. TRAVERSARI, C., VAN DER BRUGGEN, P., VAN DEN EYNDE, B., HAINAUT, P., LEMOINE, C., OHTA, N., OLD, L. and BOON, T., Transtection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics, 35, 145-152 (1992).
32. TUSSEY, L.G., ROWLAND JONES, S., ZHENG, T.S., ANDROLEWICZ, M.J., CRESSWELL, P., FRELINGER, J.A. and MCMICHAEL, A.J., Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity, 3, 65-77 (1995).
33. VAN DER BRUGGEN, P., SZIKORA, J.-P., BOEL, P., WILDMANN, C., SOMVILLE, M., SENSI, M. and BOON, T., Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw* 1601. Europ. J. Immunol., 24, 2134-2140 (1994).
34. VAN ELSAS, A., VAN DER BURG, S.H., VAN DER MINNE, C.E., BORGHI, M., MOURER, J.S., MELIEF, C.J. and SCHRIER, P.I., Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen. Europ. J. Immunol., 26, 1683-1689 (1996).
35. WÖLFEL, T., HAUER, M., KLEHMANN, E., BRICHARD, V., ACKERMANN, B., KNUTH, A., BOON, T. and MEYER ZUM BÜSCHENFELDE, K.-H., Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL). Int. J. Cancer. 55, 237-244 (1993).
36. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science, 269, 1281-1284 (1995).
37. WÖLFEL, T., KLEHMANN, E., MÜLLER, C., SCHÜTT, K.-H., MEYER ZUM BÜSCHENFELDE, K.-H. and KNUTH, A., Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leucocyte antigen A2 as a restriction element for three different antigens. J. exp. Med., 170, 797-810 (1989).
38. WÖLFEL, T., SCHNEIDER, J., MEYER ZUM BÜSCHENFELDE, K.-H., RAMMENSEE, H.-G., RÖTZSCHKE, O. and FALK, K., Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1. Int. J. Cancer, 57, 413-418 (1994).
39. ZEMMOUR, J., LITTLE, A.-M., SCHENDEL, D.J. and PARHAM, P., The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol., 148, 1941-1948 (1992).